EE329 The Value-Based Price for a Bivalent COVID-19 Booster Vaccine in the United Kingdom

por Kohli, M., Maschio, M., Lee, A., Carroll, S., Van de Velde, N., Drummond, M.
Publicado 2023

EPH155 A Systematic Review of the Impact of Vaccination on Long COVID

por Thompson, JY, Nnate, DA, Mussad, M, Carroll, S, Buck, P, Strain, WD, Banerjee, A, Van de Velde, N
Publicado 2022

EPH124 Prediction Model to Evaluate the Impact of a Next Generation Bivalent Omicron-Containing COVID-19 Booster (MRNA.1273.214) on Hospitalizations in Adults in Germany

por Müller, A, Ultsch, B, Nasir, A, Certejan, T, Buck, P, Ben, A, Raths, J, Wahler, S, Van de Velde, N
Publicado 2022

EPH117 Factors Associated with Receipt of Second Dose of mRNA-1273 Vaccine at Walgreens Pharmacies during the COVID-19 Pandemic

por Roberts, E, Shah, A, Smith-Ray, R, Buck, P, Van de Velde, N, Talarico, C, Mansi, J, Taitel, M
Publicado 2022

EE80 The Potential Clinical and Economic Benefits of a Next Generation Omicron-Containing (BA.1) Bivalent Sars-Cov-2 Booster Compared to First Generation Prototype Boosters in Germ...

por Maschio, M, Schweikert, B, Ultsch, B, Cai, R, Fust, K, Lee, A, Nasir, A, Buck, P, Van de Velde, N, Kohli, M
Publicado 2022